Objective: An increase of circulating secretory Phospholipase A (sPLA ) is a risk factor for coronary artery disease. We hypothesized 2 2 that this reflects participation of sPLA in local inflammatory reactions ensuing in ischemic myocardium. Therefore, we studied the course 
Introduction
Although animal studies have shown that local inflammatory reactions may contribute significantly (up to 65%) Impaired perfusion of the myocardium induces a local to infarct size [1-3], the contribution of inflammation to inflammatory response [1,2] comprising a complicated the extent of tissue damage following myocardial ischemia interaction of ischemic cardiomyocytes with inflammatory and infarction in humans is poorly understood. Circulating cells, cytokines, complement factors and acute phase levels of parameters that reflect inflammation, like Cproteins.
reactive protein (CRP) and serum Amyloid A, may behave as cardiovascular risk factors [4] [5] [6] [7] . Secretory phospholipase A (sPLA ), a known pro-inflammatory mediator, was recently found to be such a cardiovascular risk factor, as an in the absence of a rise in cardiac enzymes (LD, CK or increase in circulating levels of sPLA in patients with CK-MB) on admission or during the first days thereafter.
2 unstable angina can predict the outcome of clinical corPatients with (auto)immune disorders, infectious disease, onary events [8] . sPLA hydrolyses the sn-2-ester bond of malignancy or pregnancy were excluded from the study. 2 phospholipids to produce free fatty acids and lysophosFor immunohistochemical studies, patients, referred to pholipids [9] . In doing so these enzymes catalyse the rate the Department of Pathology for autopsy, were included, limiting step in the formation of several pro-inflammatory when at autopsy they showed signs of a recently developed lipid mediators like prostaglandins, leukotrienes, lipoxins AMI, i.e. decreased Lactate Dehydrogenase (LD) staining and platelet-activating factor [10] . Excessive and unconof the affected myocardium. Some of the patients particitrolled sPLA activity, has long been postulated to be a pated in earlier studies on the involvement of CRP, 2 contributing factor to the tissue damage and organ complement, ICAM-1 and CD66B in infarcted myocardysfunction that occurs in a variety of human acute and dium [14, 19] . chronic inflammatory diseases [11] . Its crucial role in the The study was approved by the ethics committee of the pro-inflammatory cascade makes it an interesting target for VU Medical Center Amsterdam and was preformed acnovel anti-inflammatory therapies. Indeed, several potent cording the institutional guidelines. Furthermore, the ininhibitors, tested in vitro and in an animal sepsis model vestigation conforms with the principles outlined in the have been developed [12, 13] . To what extent sPLA Declaration of Helsinki.
2 participates in the inflammatory cascade in ischemic myocardium however is unknown and therefore the aim of 2.2. Collection of plasma samples and laboratory this study.
investigations Recently we have shown that CRP localizes in infarcted myocardium together with activated complement fragsPLA and CRP were assessed in venous blood samples 2 ments, suggesting CRP contributes to inflammatory of 5 ml that were obtained on admission and 2, 6, 12, 24, changes ensuing locally in ischemic myocardium [14] .
48 and 72 h thereafter. These samples were collected in Indeed, in a recent study it was shown that human CRP Venoject tubes (Terumo, Rome, Italy) containing 10 mM enhances myocardial damage in a rat model for acute benzamidine 100 mg per ml soy bean trypsin inhibitor and myocardial infarction [15] . CRP has the ability to bind a to 10 mM EDTA (final concentrations) to prevent in vitro number of substances, among which are lysophospholipids activation. After centrifugation for 10 min at 1300 g the [16, 17] . These are products of the hydrolysis of the plasma was collected and stored at 2708C, until assays phospholipids of the cell membrane by activity of sPLA .
were performed. Venous samples for determination of CK-
2
We hypothesized that sPLA may be involved in the (MB) and LD were collected every 4 h after admission 2 formation of suitable ligands for binding of CRP to during the first 24 h and at 36, 48 and 72 h thereafter. CKinfarcted myocardial muscle cells [18] . Therefore, in this (MB) and LD were determined directly by specstudy, we also examined the course of sPLA in relation to trophotometer at 308C, using a centrifugal analyser (BM / 2 that of CRP in patients with AMI, and studied its presence Hitachi 747) and commercial test kits (both from Boehin ischemic myocardium.
ringer Mannheim, Mannheim, Germany). sPLA and CRP 2
were measured with ELISAs as previously described [20, 21] ST-segment elevation of $2 mV in two contiguous leads Verheijen, CMLE, Utrecht, the Netherlands). In a previous of a standard ECG), and a diagnostic rise in cardiac study we took blood samples of 19 healthy volunteers to enzymes during the hospitalisation period (serum lactate obtain normal ranges. These had an average amount of 3.4 dehydrogenase (LD), creatine kinase (CK) or creatine ng / ml sPLA (S.D.61.3). As a cut-off point 5 ng / ml was 2 kinase MB-fraction (CK-MB)). UAP was defined as considered to be elevated, as the 95th percentile of the angina at rest occurring during at least two episodes in the healthy volunteers samples was 4.9 [20] . The detection previous 48 h or in one episode lasting at least 15 min, and limit of the test was 1.0 ng / ml sPLA (S. 
Calculation of enzyme-and sPLA release during
The slides were incubated at room temperature for 10 2 AMI min with normal rabbit serum (Dakopatts A / S, Glostrup, Denmark) 1-50 diluted in phosphate buffered saline, pH Cumulative release values (Q) of LD, between the onset 7.4, containing 1%, w / v, BSA (PBS-BSA) after a rinse in of symptoms (t50) and time t, indicated as Q(t), were PBS. calculated as described [22, 23] 
from the equation:
Incubation of the slides with specific antibody solutions was performed for 60 min at room temperature (4A1 t t diluted 1:100 in PBS-BSA; 5G4 1:500 in PBS-BSA). In content of human myocardium, which is 220 U per gram hematoxylin for 40 s, dehydrated, cleared and finally of wet weight [24] , to obtain infarct size in gram-equivamounted.
21
lents of myocardium per litre of plasma (greq. l ). Microscopic criteria were used to estimate infarct duraFollowing the same approach cumulative release of sPLA tion in all myocardial tissue specimens [26, 27] . General 1.9, 0.94 and 14.1 h , respectively, as estimated for 12 and 24 h after onset of AMI were, beginning PMN equally sized and renally cleared proteins [25] .
infiltration, between 1 and 3 days, massive interstitial PMN infiltration and coagulation necrosis. Between 3 and 5 days 2.4. Processing of tissue specimens after onset of AMI, massive decay of PMN. A marker for the episode of 5-9 days after onset of AMI was the Myocardial tissue specimens were obtained, within 12 h presence of a cell rich infiltrate of lymfocytes and especialafter the patient had deceased, from the infarcted as well as ly macrophages. And between 9 and 14 days after onset of from the adjacent sites. These latter sites showed normal AMI the presence of prominent granulation tissue. Dam-LD-staining patterns and were studied as internal controls. aged fibres were characterized by the intensity of eosino-A total of 30 patients with signs of AMI at macroscopic philic staining of involved myofibers, loss of nuclei and evaluation (abnormal LD-staining pattern) were included; cross striation, infiltration of polymorphonuclear cells and 20 males (average age of death 70.7 years) and 10 females lymphocytes, and presence of fibrosis. As morphological (average age of death 75.6 years). Four patients without judgement is more reliable in paraffin slides, corresigns of AMI (normal LD-staining patterns at macroscopic sponding paraffin tissue slides were also made to confirm evaluation) were also included. Before being prepared as the ratio of jeopardized vs. non-jeopardized tissue. The cryo-sections, the tissue specimens were stored at 21968C
proportion of cardiomyocytes positive for CRP and sPLA 2 (liquid N ). The glass slides used for microscopy were was related to the area of decreased LD staining of Data analysis was performed with SPSS for Windows mounted onto glass slides, dried for 1 h by exposure to air version 9.0. As the data were not normally distributed, and fixed in acetone ('Baker Analysed Reagent', Mallinckmedian and 25th-75th percentiles were used in the tables, rodt Baker BV, Deventer, Holland). To evaluate its course during AMI, sPLA levels were AMI group than those in the UAP group. The differences 2 measured in plasma samples from patients with AMI and between the groups already were significant from t56 h, compared to those in patients with UAP (Table 1) . On up to t572 h (Fig. 1) . The increase in the cumulative Table 3 sPLA levels during each period was also significantly 2 Rise in mean cumulative CRP in patients with AMI vs. UAP with higher in the AMI group compared to the UAP group in standard error of mean and significance according to 'Kruskall Wallis'
any of the time episodes (Table 2) .
Time episode AMI (n587) UAP (n520) P value CRP was measured as well in the same plasma samples.
(h)
A detailed analysis of these data will be described else- for both the UAP and AMI group, no significant influence (Fig. 3) . Most intense staining for sPLA was found in the the rate limiting step in the formation of several proprevious study we have shown that also CRP binds to inflammatory lipid mediators [10]. Here we report an early infarcted human myocardium [14] . However, in contrast to elevation of type II PLA (further denoted as sPLA ) in CRP, sPLA was also found to bind to morphologically 2 2 2 plasma of patients suffering from acute myocardial infarcnormal cardiomyocytes, adjacent to the infarcted area (Fig.  4) . The results of the immunohistochemical studies are tion (AMI). summarized in Tables 4 and 5 . Table 4 shows that 1 out of These plasma levels started to increase at 6 h after onset 14 patients with an infarct age of less than 12 h stained of AMI. Leong et al. and Langton et al. have reported an positive for sPLA and CRP. However, the area staining increase of PLA activity at a later episode in plasma of 2 2 positive in this patient was relatively low being 5-10%. patients suffering from AMI, respectively at 2-4 days and More extensive localization of sPLA was found in two of 24-36 h after onset of symptoms [28, 29] . Calculation of 2 the three infarcts of 12-24 h. CRP appeared in infarcts of the cumulative release values allowing for the alignment of more than 24 h (Table 4 ). In general, the area of the infarct our results to the onset of symptoms of AMI [22, 23] , containing sPLA was larger than that where CRP was presumably explains why we could detect significant 2 localized ( bond of phospholipids to produce free fatty acids and many other cells including endothelial cells, fibroblasts, lysophospholipids [9] . In doing so these enzymes catalyse smooth muscle cells and HepG2 cells, a hepatocarcinoma Table 4 cell-line considered to represent an in-vitro model to study References CRP in the activation of complement ensuing locally in the infarcted myocardium [14] . CRP has the ability to bind to products of sPLA activity, namely lysophospholipids onstrated in infarcted myocardium [38] . Therefore, we 
